Cho, K. Y., Yokoyama, H., Atsumi, T., Nomoto, H., Takeuchi, J., Nagai, S., . . . Kameda, H. Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: Protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study). BMJ Publishing Group.
Chicago Style (17th ed.) CitationCho, Kyu Yong, et al. Effects of Switching from a Dipeptidyl Peptidase-4 Inhibitor to Oral Semaglutide on Glucose Metabolism in Patients with Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-label, Parallel-group Comparison Study (the SWITCH-SEMA 2 Study). BMJ Publishing Group.
MLA (9th ed.) CitationCho, Kyu Yong, et al. Effects of Switching from a Dipeptidyl Peptidase-4 Inhibitor to Oral Semaglutide on Glucose Metabolism in Patients with Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-label, Parallel-group Comparison Study (the SWITCH-SEMA 2 Study). BMJ Publishing Group.